We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

10 hedge funds and large institutions have $447K invested in ImmuCell in 2013 Q2 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SRC
1
Shufro Rose & Co
New York
$192K +$184K +51,263 New
Morgan Stanley
2
Morgan Stanley
New York
$111K +$106K +29,628 New
EFS
3
Essex Financial Services
Connecticut
$89K +$85.2K +23,776 New
Renaissance Technologies
4
Renaissance Technologies
New York
$38K +$35.8K +10,000 New
Bank of America
5
Bank of America
North Carolina
$8K +$7.28K +2,032 New
U
6
UBS
Switzerland
$7K +$6.7K +1,870 New
TRCT
7
Tower Research Capital (TRC)
New York
$1K +$910 +254 New
Creative Planning
8
Creative Planning
Kansas
$1K +$1.11K +310 New
Wells Fargo
9
Wells Fargo
California
– +$4 +1 New
US Bancorp
10
US Bancorp
Minnesota
– +$86 +24 New

ICCC Hedge Fund Activity: Q2 2013 in Review

10 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2013, worth a combined $447K.

Buyers outnumbered sellers: 10 funds opened new ICCC positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.

  • 10 institutional investors held ImmuCell (ICCC) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $447K of ImmuCell stock for Q2 2013.
  • 10 funds opened new ImmuCell positions in Q2 2013 and 0 closed out, a net change of +10 holders.

Based on aggregated 13F filings for Q2 2013.